SCHEMBL6154500

SCHEMBL6154500

Clc1ccc(NCc2ccc3ccccc3c2)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 1/20 0.59
IGF1R P08069 1/20 0.59
FFAR1 O14842 2/20 0.54
MAPT P10636 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ATM Q13315 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MRGPRX4 Q96LA9 1/20 0.50
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HIF1A Q16665 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MC4R P32245 2/20 0.45
MC5R P33032 2/20 0.45
MC3R P41968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6696440 0.88 INSR (0.56) INSRIGF1RFFAR1MAPTMEN1
SCHEMBL20036943 0.86 INSR (0.75) INSRIGF1RFFAR1MRGPRX4ALDH1A1
SCHEMBL27527525 0.83 FFAR1 (0.60) INSRIGF1RFFAR1MEN1KMT2A
Hydrochloric Acid SCHEMBL6419281 0.82 FFAR1 (0.58) INSRIGF1RFFAR1MEN1KMT2A
SCHEMBL11511690 0.81 MEN1 (0.60) FFAR1MAPTMEN1KMT2AATM
SCHEMBL6692765 0.81 INSR (0.49) INSRIGF1RFFAR1MAPTMEN1
SCHEMBL9093298 0.79 FFAR1 (0.67) INSRIGF1RFFAR1MAPTMEN1
SCHEMBL29606754 0.79 FFAR1 (0.67) INSRIGF1RFFAR1MAPTMEN1
SCHEMBL6158041 0.79 FFAR1 (0.54) FFAR1MAPTMEN1KMT2AATM
SCHEMBL11117945 0.78 FFAR1 (0.62) FFAR1MAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP INSR 4283/4885IGF1R 2527/4885FFAR1 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.